GLP-1 treatment usually begins at a low dose. If your physician approves an increase, the medicine price can rise with the dose. The care fee remains separate and predictable.
Medication Pricing
What the medicine costs,before you commit to anything.
Four prescription treatments, the dose ladder for each, and the real month by month cost of a Juuno programme. Nothing is prescribed and nothing is charged for medicine until a licensed physician has reviewed your case.
1. The price is per dose, not per medicine. Cost rises as your dose steps up.
2. Care and medicine are billed separately. One figure without the other is not the full picture.
3. A higher dose is not a better outcome. Many patients hold at a middle dose for good.
Clinical review comes first
No medicine is selected at checkout. A physician decides.
Prices include GST
Cold chain delivery where the medicine requires it.
Prescription only
Neither the medicine nor the dose is guaranteed.
Cost planner
See the whole spend, not the first month.
GLP-1 treatment gets more expensive as the dose steps up. Pick a medicine, a care plan and a duration to see how the monthly figure actually moves.
Month by month
Care feeMedicine
Standard titration over 6 months. Physician review before every dose increase.
Month 12.5 mg
₹31,098
Month 25 mg
₹34,098
Month 35 mg
₹34,098
Month 47.5 mg
₹38,098
Month 57.5 mg
₹38,098
Month 67.5 mg
₹38,098
Estimate only. It assumes a standard titration pace and current catalogue prices. Your physician sets the medicine, dose and speed of any increase after reviewing your history, contraindications and response. The payable amount is confirmed before every dispatch.
Treatment reference
Every dose, every price, in the open.
Useful when your physician prescribes a different dose, or when a dose increase is approved partway through your programme.
Tirzepatide · GIP and GLP-1 receptor agonist
Mounjaro
A once weekly dual action treatment. Programmes start at 2.5 mg and move up only when the prescribing physician confirms the next step.
Monthly supply, per pen
Step 12.5 mg
Step 25 mg
Step 37.5 mg
Step 410 mg
Step 512.5 mg
Step 615 mg
Monthly medicine pricing
Useful when a physician prescribes a different dose or approves an increase.
| Dose | MRP | Juuno price |
|---|---|---|
| 2.5 mgStarting | ₹16,999 | ₹13,999 |
| 5 mgCommon | ₹19,999 | ₹16,999 |
| 7.5 mg | ₹24,999 | ₹20,999 |
| 10 mg | ₹24,999 | ₹20,999 |
| 12.5 mg | ₹29,999 | ₹25,999 |
| 15 mgMaximum | ₹29,999 | ₹25,999 |
Treatment commonly begins at the lowest listed dose. Any increase depends on physician review and how well you tolerate the current dose.
Side by side
All four treatments in one view.
Your physician chooses the treatment. This is here so the choice makes sense to you when they explain it.
| Treatment | Molecule | How it is taken | Starting dose cost | Typical maintenance | Best suited to |
|---|---|---|---|---|---|
| Mounjaro | Tirzepatide | Once weekly injection, per pen | ₹13,9992.5 mg a month | ₹16,999at 5 mg | Patients who need the strongest average response and can tolerate a slow, stepped increase. |
| Wegovy | Semaglutide | Once weekly injection, per pen | ₹5,9990.25 mg a month | ₹9,499at 1 mg | Patients suited to a licensed weight management indication with a well documented dose ladder. |
| Ozempic | Semaglutide | Once weekly injection, per pen | ₹5,9990.25 mg a month | ₹8,499at 0.5 mg | Patients with metabolic markers to manage alongside weight, where 1 mg maintenance is enough. |
| Rybelsus | Oral semaglutide | Daily tablet, 30 tablets a month | ₹9,4993 mg a month | ₹10,499at 7 mg | Patients who would not start, or would not continue, an injectable treatment. |
Maintenance figures show the monthly medicine cost at the dose most patients settle on. Suitability is decided in consultation, never from a table.
Two separate bills
What the care fee covers, and what it does not.
Inside the Juuno care fee
Billed monthly to Juuno. It continues whether or not medicine is prescribed.
- Physician consultations and monthly clinical follow-up
- Eligibility review, lab interpretation and dose decisions
- Dietitian and movement plan built around your capacity
- Side effect management and unlimited care team messaging
- Metabolic marker tracking through the patient portal
Billed separately
Charged by the licensed pharmacy partner only after a prescription is issued.
- The medicine itself, priced by dose
- Cold chain delivery where the treatment requires it
- Any dose increase approved partway through the programme
- Optional add ons such as CGM sensors or a DEXA scan
- Lab panels beyond the ones your plan includes
Why we split it
Bundling medicine into a single programme price makes the prescribing decision look like a purchase decision. Keeping them separate means your physician can hold you at a lower dose, switch treatment, or stop medicine altogether without any of it costing Juuno money. That is the point.
Safety and billing
Clear prices. Clinical decisions stay clinical.
Prescription treatment
Eligibility, medicine, dose and treatment pace are decided independently by the treating physician after reviewing contraindications, history and current medication. Assessment does not guarantee a prescription.
Licensed fulfilment
An approved prescription is filled by a licensed pharmacy partner. Juuno does not manufacture, store or dispense medication, and does not hold stock of any kind.
Billing terms
Care is billed monthly and can be cancelled with notice. Medicine already processed for shipment may be non cancellable and non refundable under the applicable policies.
FAQ
Frequently Asked Questions
A clinical pathway with four stages. Each step is led by a qualified professional and adapted to your body, history, and response to therapy.
No. Your Juuno care fee covers end-to-end clinical care. A licensed pharmacy partner bills prescribed medicine separately, only after the prescription is issued.
Your physician will explain why and discuss appropriate next steps. Completing an eligibility review never guarantees a prescription.
A higher dose is not automatically a better outcome. Your physician may hold a lower dose when it is effective and well tolerated, but clinical need—not price alone—determines dosing.
